31 related articles for article (PubMed ID: 24763359)
21. Synthesis and characterisation of low valent Mn-complexes as models for Mn-catalases.
Berggren G; Huang P; Eriksson L; Styring S; Anderlund MF; Thapper A
Dalton Trans; 2010 Dec; 39(45):11035-44. PubMed ID: 20957239
[TBL] [Abstract][Full Text] [Related]
22. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer.
Wang Z; Wang D; Han S; Wang N; Mo F; Loo TY; Shen J; Huang H; Chen J
PLoS One; 2013; 8(2):e56631. PubMed ID: 23457597
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, cytotoxicity for mimics of catalase: inhibitors of lactate dehydrogenase and hypoxia inducible factor.
Xue JJ; Chen QY; Kong MY; Zhu CY; Gen ZR; Wang ZL
Eur J Med Chem; 2014 Jun; 80():1-7. PubMed ID: 24763359
[TBL] [Abstract][Full Text] [Related]
24. Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.
Rani R; Kumar V
J Med Chem; 2016 Jan; 59(2):487-96. PubMed ID: 26340601
[TBL] [Abstract][Full Text] [Related]
25. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
Zhang SL; He Y; Tam KY
Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
[TBL] [Abstract][Full Text] [Related]
26. Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment.
Di Stefano G; Manerba M; Di Ianni L; Fiume L
Future Med Chem; 2016 Apr; 8(6):713-25. PubMed ID: 27054686
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule inhibitors of human LDH5.
Granchi C; Paterni I; Rani R; Minutolo F
Future Med Chem; 2013 Oct; 5(16):1967-91. PubMed ID: 24175747
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
